Female Viagra 'Has No Significant Effect'

Researchers have emphasized in a report that the pink pill, known as Addyi or female Viagra, has no significant effect on treating women's sexual desire disorders. According to Bloomberg News, a group of researchers from Erasmus University in Rotterdam, Netherlands, published a report in the International Journal of JAMA, stating that their research results on nearly six thousand women from eight different scientific studies show that, considering the side effects of this drug, its effect on increasing women's sexual desire is not scientifically significant. The drug Addyi, produced and distributed by the pharmaceutical group Valeant, was approved last summer by the U.S. Food and Drug Administration but failed to gain much support among both doctors and consumers. This drug aims to treat sexual desire disorders in premenopausal women. It is estimated that between ten to forty percent of women in the U.S. suffer from sexual desire disorders, a condition with no clear cause. Valeant's stock has also been on a downward trend since summer. Consumers of this pink pill have reported side effects such as dizziness, drowsiness, nausea, and lethargy after taking it. Now, researchers from Erasmus University state that this drug, scientifically known as flibanserin, should not be prescribed for treating low sexual desire in women until more detailed research is conducted on it. Currently, there is little information about the effect of this drug on women who have had to undergo hysterectomy or are taking other hormonal medications. Researchers say that with the limited current information, they have concluded that the effect of this drug on women is negligible. According to Medical Press, since there is no specific scientific measure for sexual satisfaction, measuring the success rate of this drug becomes more challenging. One of the authors of this research stated that, unlike cholesterol, which has a clear healthy or unhealthy level for the body, there is no specific measurement system for sexual desire, and it cannot be said what level of sexual desire is sufficient or necessary.